Tag: Piper Jaffray

Despite Aurora Cannabis providing higher-than-expected guidance for fiscal 2019's fourth quarter early this year, its stock has fallen 25.6% this month.

Piper Jaffray has rated Cronos Group as “overweight.” The investment company has given Cronos Group a 12-month price target of $18.